Move towards funding for EU cross-border projects
This article was originally published in Clinica
One more step has been taken towards making the European Commission's funding programme of projects relating to health in 2007-13 a reality. The EU Health Ministers Council reached a political agreement on November 30 on the programme, which has a proposed budget of E365.6m ($482m).
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.